Skip to content

Use of intravenous drugs in short urinary tract procedures for early recovery.

Comparison of effects of dexmedetomidine-ketamine and midazolam-ketamine combination in transurethral procedures.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048343
Enrollment
44
Registered
2022-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Dexmedetomidine-Ketamine: The drug combination will be administered as ketamine 1 mg kgâ??1 and dexmedetomidine 1 µg kgâ??1 i.v. in 20 ml of normal saline over 10 minutes followed by

Sponsors

Sangey Doma Tamang
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA physical status 1 and 2. Patients able to comprehend and willing to participate. Patients scheduled for elective transurethral procedures.

Exclusion criteria

Exclusion criteria: Patientâ??s refusal to participate. Patients with known contraindication or sensitivity to study drugs. Patients on concomitant analgesic, sedative medication, or chronic use of an α-agonist. Patients with chronic renal insufficiency, liver dysfunction, psychiatric or emotional disorders, respiratory disorders, sleep apnea, second or third degree heart block.

Design outcomes

Primary

MeasureTime frame
Recovery time and return of full psychomotor function by achieving the Aldrete score to 10 points.Timepoint: 10 mins, 20 mins, 30 mins, 40 mins, 50 min, 60 mins, 70 mins, 80 mins, 90 mins

Secondary

MeasureTime frame
Analgesic/sedative effect of Dexmedetomidine- Ketamine and Ketamine- Midazomlam combinations (Requirement of rescue medications) Timepoint: 10 mins, 20 mins, 30 mins, 40 mins, 50 mins, 60 mins, 70 mins, 80 mins, 90 mins

Countries

India

Contacts

Public ContactDr Prakash Kumar Dubey

Indira Gandhi Of Medical Sciences

pkdubey@hotmail.com9430511851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026